The next board meeting for Lyra Therapeutics Inc is on 13 Mar 2026 for the purpose of Lyra Therapeutics Inc Fourth Quarter Earnings Results for 2025See details
Lyra Therapeutics Inc has a share price target of US$ 16, revenue growth forecast of -51.6%, and profit growth estimate of 62.9% for FY25, based on top 1 analyst call.